Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia

NCT02824380 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Androgenic Alopecia

Interventions

DRUG: DA-4001 H
DRUG: DA-4001 L

Sponsor

Dong-A ST Co., Ltd.